Treatment for Multiple Sclerosis

The illness that is called MS or Multiple Sclerosis is a chronic and progressive illness which targets the different nerves in the brain, spinal cord as well as other parts of the central nervous system.

It is an autoimmune disease which translates to the body’s immune system targeting itself. It attacks cells, organs as well as tissues which are perfectly fine. If you have multiple sclerosis, you are not alone as it affects over 400,000 people in the United States alone and may possibly affect 2.5 million people worldwide. One trivia is that it affects 2-3 as many women as men.

Interferon beta-1B (Betaseron)

There are several treatment options for those who are suffering from Multiple Sclerosis (MS). One of which is the administering of the drug "Interferon beta-1b" or Betaseron. This is injected under the skin every other day. Interferons are substances which are manufactured by the body to help maintain the immune system.

In this particular case, the diminishing activity of some specific white blood cells is desired in order to tone down the cells responsible for the disease. What Betaseron does is it decreases the rate of relapse as well as slows down the development of new lesions on the patient. It also delays the progression of disability.

Corticosteroids (methylprednisolone, prednisone, dexamethasone)

For primary progressive as well as progressive/relapsing Multiple Sclerosis Treatment, there is no treatment that is currently approved however there are disease modifying therapies which may possibly reduce the progression of MS. These will be beneficial for the patient who is seeking available medical relief.

There are short-term treatments with corticosteroids such as prednisone, methylprednisolone, dexamethasone and some others. These are able to aid in the periods of acute relapse and the mechanism by which corticosteroids work is by decreasing the body’s defense system reaction to the myelin contained in a person’s central nervous system. This will eventually hasten the recovery from acute attacks and will essentially prevent further damage to the blood-brain barrier.

The various treatments for MS significantly focus on decreasing the rate as well as the severity of relapse while reducing the number of MS lesions. It delays the progression of the disease while being able to provide symptomatic relief for the MS patient. These are just some of the drugs which have been developed. Further research into the illness will probably reveal new and better drugs for the relief of all sufferers of MS.

 
You can leave a response, or trackback from your own site.